Anti-HHV-8 glycoprotein B/gB Antibody (SAA2420) from ProteoGenix; catalogue ARO-A22860; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-HHV-8 glycoprotein B/gB antibody (SAA2420) is a highly specific and sensitive tool for studying and combating HHV-8 infection. This antibody is a valuable addition to any biotech research arsenal, offering a comprehensive understanding of HHV-8 biology and its role in various diseases.
HHV-8, also known as Kaposi’s sarcoma-associated herpesvirus (KSHV), is a gamma-herpesvirus that is associated with several diseases, including Kaposi’s sarcoma, primary effusion lymphoma, and multicentric Castleman’s disease. The glycoprotein B/gB is a key viral envelope protein that plays a crucial role in HHV-8 entry into host cells. By targeting this protein, the anti-HHV-8 gB antibody (SAA2420) enables researchers to study the virus’s mechanisms of infection and develop potential treatments.
This antibody is an essential tool for studying HHV-8 infection and its related diseases. It can be used in a variety of applications, including immunofluorescence, immunohistochemistry, and Western blotting. Its high specificity and sensitivity make it ideal for detecting the presence of HHV-8 in tissue samples and cell cultures.
The anti-HHV-8 gB antibody (SAA2420) has been used in various research studies to investigate the role of HHV-8 in different diseases. For example, it has been used to study the expression of HHV-8 in Kaposi’s sarcoma lesions and to identify potential therapeutic targets for the disease. It has also been used to detect HHV-8 in primary effusion lymphoma and to investigate the virus’s role in the development of this type of cancer. Additionally, this antibody has been used to study the interaction of HHV-8 with host cells and to identify potential treatments that can disrupt this interaction.
The anti-HHV-8 gB antibody (SAA2420) is a powerful tool for understanding and treating HHV-8 infection. Its high specificity and sensitivity make it ideal for studying the virus’s biology and its role in diseases such as Kaposi’s sarcoma and primary effusion lymphoma. With this antibody, researchers can gain valuable insights into HHV-8 and develop potential treatments for related diseases.
In summary, the anti-HHV-8 gB antibody (SAA2420) is a crucial component for any biotech research focused on HHV-8. Its ability to target the key viral envelope protein, gB, makes it a valuable tool for studying the virus’s biology and developing potential treatments. With its various applications and proven success in experimental studies, this antibody is a must-have for any research team working on HHV-8. Order yours today and unlock the full potential of your research.
ProteoGenix catalogue number ARO-A22860. For research use only.
Target: Envelope glycoprotein gB, ORF8, ORF8; Clonality: Monoclonal Antibody; Applications: ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA |
|---|---|---|---|---|---|---|---|---|
| Envelope glycoprotein gB, ORF8, ORF8 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.